Open access publisher BioMed Central has announced the launch of a new journal Cancer & Metabolism with a selection of articles that highlight the altered metabolic pathways that drive cancer.
The launch issue of the journal includes pioneering research that for the first time observes the Warburg effect during normal cerebellum development, as well as in medulloblastoma, a childhood cancer, which is accompanied by a Commentary in BMC Biology; a study on the crucial role of sterol regulatory element binding protein in lipid synthesis for cell survival and tumor growth; new imaging methods for measuring chemotherapy responses; as well as timely reviews on activated lymphocytes as a model for carcinogenesis and the discovery of the mitochondrial pyruvate carrier.
Cancer & Metabolism is edited by clinician scientists Chi Van Dang, Abramson Cancer Center, USA, and Michael Pollak, Segal Cancer Center and McGill University, Canada. The journal welcomes studies on molecular biology and genetics; whole-body metabolism, including diabetes and obesity, in relation to cancer; cancer metabolomics and metabolism-based imaging. The journal accepts basic research as well as preclinical and clinical studies of metabolism-related cancer therapies.
